2nd Quarter - Report
THE SMITH-FREE GROUP, LLC for GVB BIOPHARMA
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Agriculture AGR
Discussions relating to regulation of the CBD industry Discussions relating to Farm Bill Reauthorization Discussions relating to regulation of Delta-8 THC Monitored H.R. 2891, the SAFE Banking Act of 2023 Monitored S. 1323, the SAFE Banking Act of 2023 Monitored discussions related to providing banking services to a legitimate cannabis-related business Monitored executive branch nominations to federal agencies and commissions
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN CHRISTIE | — |
| MICHAEL A. GAFFIN | — |
| TREVOR W. KOLEGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.